W. Rachel Duan

Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist

Hugh S. Taylor, Linda C. Giudice, Bruce A. Lessey et al. · New England Journal of Medicine · 2017 · 466 citations · Full text

Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials

Geert D’Haens, Remo Panaccione, Filip Baert et al. · The Lancet · 2022 · 362 citations

Rheumatology, Induction Therapy, Immunology +9

Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial

Marc Ferrante, Remo Panaccione, Filip Baert et al. · The Lancet · 2022 · 294 citations

Fortify Maintenance Trial, Rheumatology, Withdrawal Phase 3 +7

A 14-week, Randomized, Double-Blinded, Placebo-Controlled Monotherapy Trial of Pregabalin in Patients With Fibromyalgia

Lesley M. Arnold, I. Jon Russell, Erdal Diri et al. · Journal of Pain · 2008 · 273 citations

Health Sciences, Pain Medicine, Placebo-controlled Monotherapy Trial +4

Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn’s Disease

Laurent Peyrin‐Biroulet, J. Casey Chapman, Jean‐Frédéric Colombel et al. · New England Journal of Medicine · 2024 · 126 citations · Full text